RXDX - Prometheus Biosciences - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

RXDX is currently covered by 12 analysts with an average price target of $2.27. This is a potential upside of $2.27 (0%) from yesterday's end of day stock price of $0.

Prometheus Biosciences's activity chart (see below) currently has 24 price targets and 54 ratings on display. The stock rating distribution of RXDX is 77.14% BUY and 22.86% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 79.08% with an average time for these price targets to be met of 100.46 days.

Highest price target for RXDX is $200, Lowest price target is $138, average price target is $2.27.

Most recent stock forecast was given by GREGORY RENZA from RBC on 10-May-2023. First documented stock forecast 06-Apr-2021.

Currently out of the existing stock ratings of RXDX, 27 are a BUY (77.14%), 8 are a HOLD (22.86%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

200

$0.08 (0.04%)

140

10 months 18 days ago

5/7 (71.43%)

$5.84 (3.01%)

49

Hold

160

$-39.92 (-19.97%)

160

10 months 18 days ago

1/2 (50%)

$-34.16 (-17.59%)

52

Hold

139

$-60.92 (-30.47%)

139

11 months 10 days ago

4/5 (80%)

$-54.5 (-28.17%)

138

Hold

138

$-61.92 (-30.97%)

67

11 months 10 days ago

2/3 (66.67%)

$-55.5 (-28.68%)

93

Hold

200

$0.08 (0.04%)

139

11 months 10 days ago

5/6 (83.33%)

$6.5 (3.36%)

116

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is RXDX (Prometheus Biosciences) average time for price targets to be met?

On average it took 100.46 days on average for the stock forecasts to be realized with a an average price target met ratio 79.08

Which analyst has the current highest performing score on RXDX (Prometheus Biosciences) with a proven track record?

YATIN SUNEJA

Which analyst has the most public recommendations on RXDX (Prometheus Biosciences)?

Yatin Suneja works at GUGGENHEIM and has 9 price targets and 5 ratings on RXDX

Which analyst is the currently most bullish on RXDX (Prometheus Biosciences)?

Chris Carey with highest potential upside - $25.53

Which analyst is the currently most reserved on RXDX (Prometheus Biosciences)?

Thomas Smith with lowest potential downside - -$139.92

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?